Unicharm Corporation

8113.T · Consumer Defensive · Household & Personal Products · Valued as of 2026-11-03 · Statements 2025-12-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

10.74B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

6.78B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

7.25B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

8.26B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

10.08B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.82×

the ratio the screener ranks by

Margin of Safety

-22.1%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 10.74B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)8.76B USD
+②Net Cash Today1.99B USD
+③Growth Value0 USD
=Value10.74B USD

EPV of the Operations (NOPAT over WACC)

8.76B USD

Net cash today

+1.99B USD

Growth Value

0 USD

Value

10.74B USD

①EPV (Earnings Power Value)

8.76B USD

②Net Cash Today

1.99B USD

③Growth Value

0 USD

Market value

Market Cap10.08B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+6.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 6.78B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE3.21B USD
+②Equity at Year 15, Today3.57B USD
=Value6.78B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

3.21B USD

②Equity at Year 15, Today

3.57B USD

Market value

Market Cap10.08B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-48.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 7.25B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF3.57B USD
+②Invested Capital at Year 15, Today1.69B USD
+③Net Cash Today1.99B USD
=Value7.25B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

3.57B USD

②Invested Capital at Year 15, Today

1.69B USD

③Net Cash Today

1.99B USD

Market value

Market Cap10.08B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-39.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.18%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.26×Market Risk Premium 6.00%= 6.06%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 220.98M USDPretax Income 674.44M USD= 32.76%

The tax the interest saves.

Interest Expense =EBIT 699.58M USD−Pretax Income 674.44M USD= 25.14M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 25.14M USDTotal Debt 82.36M USD×(1 − Tax Rate for WACC 32.76%)= 20.52%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 82.36M USDMarket Cap + Total Debt 10.08B USD + 82.36M USD= 0.81%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.19%×Cost of Equity 6.06%+Debt Weight 0.81%×Cost of Debt 20.52%= 6.18%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 7.61B USD − Total Liabilities 2.01B USD = Book Value Today 5.61B USD

Total Debt 82.36M USD − Cash and Short-Term Investments 2.07B USD = Net Debt Today -1.99B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-2.8%at most 5%passes1,720,800,317 / 1,770,685,638
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.6%at least -10.0%passes(841.37M USD − 417.34M USD) ÷ 7.61B USD
Price to bookMarket Cap ÷ Book Value Today1.80×at most 3×passes10.08B USD ÷ 5.61B USD
Operating marginOperating Income ÷ Revenue10.8%above 10.0%passes652.64M USD ÷ 6.05B USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-4.1%above 10.0%does not pass6.05B USD / 6.31B USD
Net cash(Cash − Total Debt) ÷ Market Cap14.8%above -30%passes(1.57B USD − 82.36M USD) ÷ 10.08B USD
Operating efficiencyOperating Income ÷ Gross Profit27.6%above 25.0%passes652.64M USD ÷ 2.37B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

918.42 JPY

Enterprise value

1.43T JPY

the provider's own figure

EV / EBITDA

9.04×

Price / book

1.95×

the provider's book

Price / earnings

24.65×

Return on equity

8.3%

the provider's figure, not this page's

Profit margin

6.7%

Revenue growth

6.9%

Analyst target, mean

1121.69 JPY

Analysts

14

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

Income statement (USD)2022202320242025

Revenue

6.76B6.67B6.31B6.05B

Gross profit

2.47B2.49B2.49B2.37B

Operating income

867.75M925.11M859.25M652.64M

EBITDA

operating income before depreciation and amortisation

1.22B1.28B1.22B1.01B

Pretax income

871.41M936.44M857.81M674.44M

Net income

509.16M609.06M521.82M417.34M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

509.16M609.06M521.82M417.34M

R&D

————
Balance sheet, year end (USD)2022202320242025

Total assets

7.90B8.02B7.91B7.83B

Total liabilities

2.57B2.44B2.34B2.12B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

4.66B4.92B4.93B5.09B

Total debt

203.50M202.17M171.20M70.75M

Cash and equivalents

1.64B1.80B1.66B1.62B

Net PP&E

fixed assets after depreciation

2.05B2.02B1.87B1.76B

Working capital

current assets less current liabilities

2.61B2.61B2.36B2.42B
Cash flow (USD)2022202320242025

Operating cash flow

694.49M1.15B874.14M841.37M

Capital expenditure

paid out, so below zero

-248.15M-271.87M-250.74M-183.20M

Depreciation and amortisation

312.43M306.13M296.73M305.96M

Free cash flow

operating cash flow plus capital expenditure

446.34M877.66M623.40M658.17M